2nd Quarter - Amendment

PFIZER INC. for PFIZER INC.

Firm
Client
Income
—
Expenses
$1,950,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 20, 2018 $1,940,000 Replaced
2nd Quarter - Amendment Jul 25, 2018 $1,940,000 Replaced
2nd Quarter - Amendment (this page) Oct 21, 2018 $1,950,000 Yes

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Comprehensive Corporate Tax Reform

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
CAROLINE MOODY SCHELLHAS —

Contacted: Health & Human Services, Dept of (HHS); Treasury, Dept of; White House Office; SENATE; U.S. Trade Representative (USTR); Natl Economic Council (NEC); Natl Security Council (NSC); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); Office of the Vice President of the United States; Executive Office of the President (EOP); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill Trans-Atlantic trade & Investment Partnership Canada IP/Trade Issues South Africa IP Issues China IP Indonesia IP Thailand IP Korea Pricing Issues United Nations Health Panel G7/G20 APEC OECD Australia Market - Size Damages WTO "Zero for Zero" Pharmaceutical Agreement NAFTA

LobbyistCovered position, as disclosed
DOUGLAS REID GOUDIE —

Contacted: Food & Drug Administration (FDA); Commerce, Dept of (DOC); Executive Office of the President (EOP); White House Office; Health & Human Services, Dept of (HHS); Natl Security Council (NSC); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Natl Economic Council (NEC); Treasury, Dept of; Office of the Vice President of the United States; SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS)

Health Issues HCR

Drug Pricing Biosimilars Reimbursement Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA

LobbyistCovered position, as disclosed
PAULA BURG —
KEN W COLE —
JOHN PAUL HALLIWELL —
ROBERT JONES New —
EMILY MUELLER New Legislative Correspondent; Legislative Assistant; Legislative Director; Senior Health Policy Advisor; Deputy Legislative Director
ANGELA WALKER RIEMER —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Food & Drug Administration (FDA); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Office of the Vice President of the United States; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); SENATE; Treasury, Dept of; White House Office; Patent & Trademark Office (PTO); Natl Economic Council (NEC)

Copyright/Patent/Trademark CPT

Creates Act Patent Settlements Transferable exclusivity

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ROBERT JONES New —
EMILY MUELLER New Legislative Correspondent; Legislative Assistant; Legislative Director; Senior Health Policy Advisor; Deputy Legislative Director
ANGELA WALKER RIEMER —

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Treasury, Dept of; Office of the Vice President of the United States; Health & Human Services, Dept of (HHS); White House Office; Food & Drug Administration (FDA); Natl Security Council (NSC); SENATE; Patent & Trademark Office (PTO); State, Dept of (DOS); U.S. Trade Representative (USTR); Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS)

Alcohol and Drug Abuse ALC

Prescription Drug Abuse

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ROBERT JONES —
EMILY MUELLER New Legislative Correspondent; Legislative Assistant; Legislative Director; Senior Health Policy Advisor; Deputy Legislative Director
ANGELA WALKER RIEMER —

Contacted: Commerce, Dept of (DOC); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); State, Dept of (DOS); Natl Security Council (NSC); Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS); Office of the Vice President of the United States; Treasury, Dept of; U.S. Trade Representative (USTR); White House Office; SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Medicare Part D Coverage Gap Biosimilar pass-through

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ROBERT JONES New —
ANGELA WALKER RIEMER —

Contacted: Executive Office of the President (EOP); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Natl Economic Council (NEC); SENATE; Treasury, Dept of; HOUSE OF REPRESENTATIVES; White House Office; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Office of the Vice President of the United States; Commerce, Dept of (DOC); Natl Security Council (NSC); Patent & Trademark Office (PTO)

Budget/Appropriations BUD

2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018 Omnibus Appropriations Act of 2018

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ROBERT JONES New —
ANGELA WALKER RIEMER —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Patent & Trademark Office (PTO); White House Office; State, Dept of (DOS); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Executive Office of the President (EOP); SENATE; Natl Economic Council (NEC); Natl Security Council (NSC); Treasury, Dept of; Office of the Vice President of the United States

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.